Material weakness disclosures in an IPO
More companies are disclosing material weaknesses in their IPO filings to provide greater transparency with investors.
Featured - 4 items
- 100 results
- Reset filters
Loading...
Forensics Today: Mitigating fraud risk in nonprofits
Nonprofits are especially vulnerable to fraud because they typically operate in high-trust environments with less oversight. Learn how organizations can adapt in PwC’s “Forensics Today” series.
IPO market faces renewed uncertainty
While IPO activity thus far is in line with 2024 levels and has outperformed the lows of 2022 and 2023, challenges remain.
Three new ideas to unlock additional value creation in M&A integration
PwC has identified three key levers that drive more sustained outcomes for acquirers.
Going public? What you need to know about corporate governance
Going public can open up exciting opportunities for a company, but it involves more governance decisions than directors may expect.
GE split: Deals Transformation & Innovation
Discover how PwC helped GE split into three industry-leading companies, fueling bold innovation, global efficiency, new growth possibilities, and deals transformation.
The corporate director’s guide to overseeing deals
The success, survival, or downfall of a company can hinge on its transaction strategy. It is the board’s responsibility to ensure the company remains on the right path.
Successfully navigating M&A under the new HSR rules
Hart-Scott-Rodino Act filing changes have significant impacts on private equity firms and other serial acquirers that frequently engage in M&A activity and have many subsidiaries.
Sports Industry Outlook 2025
What’s next in sports: from private equity involvement to innovative fan experiences, PwC unpacks the hottest trends. Dive into the playbooks and articles.
Accounting for cloud computing arrangements
Business model change is being driven and facilitated by cloud-based technologies and other powerful software capabilities.
Health industries
PwC’s Health Industries practice provides guidance in key areas impacting healthcare, pharmaceutical, life sciences and medical device organizations.
Industrial products and services
Empowering industries with assurance, tax and consulting services across energy, utilities, aerospace, automotive, chemicals, manufacturing and construction.
Insurance: US Deals 2025 outlook
In a complex market, insurance deal activity rebounds in the second half of 2024.
Banking and capital markets: US Deals 2025 outlook
We expect activity to keep rising, helped by the Federal Reserve’s pivot to lowering rates and the Republican sweep in the election.
US Deals 2025 outlook
The uneven US M&A recovery will likely accelerate in 2025 as dealmakers digest the implications of a new regulatory regime.
Asset and wealth management: US Deals 2025 outlook
Deals continue to be driven primarily by companies’ attempts to boost revenue through expanding into new markets and products.
Loading...
Follow us
